Dimethyl Sulfoxide Attenuates Acute Lung Injury Induced by Hemorrhagic Shock/Resuscitation in Rats |
| |
Authors: | Yu-Chi Tsung Chih-Yang Chung Hung-Chieh Wan Ya-Ying Chang Ping-Cheng Shih Han-Shui Hsu Ming-Chang Kao Chun-Jen Huang |
| |
Affiliation: | 1.Division of Surgical Intensive Care Unit, Department of Surgery,Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation,New Taipei City,Taiwan;2.Institute of Emergency and Critical Care Medicine, School of Medicine,National Yang-Ming University,Taipei,Taiwan;3.Department of Anesthesiology,Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation,New Taipei City,Taiwan;4.School of Medicine,Tzu Chi University,Hualien,Taiwan |
| |
Abstract: | Inflammation following hemorrhagic shock/resuscitation (HS/RES) induces acute lung injury (ALI). Dimethyl sulfoxide (DMSO) possesses anti-inflammatory and antioxidative capacities. We sought to clarify whether DMSO could attenuate ALI induced by HS/RES. Male Sprague-Dawley rats were allocated to receive either a sham operation, sham plus DMSO, HS/RES, or HS/RES plus DMSO, and these were denoted as the Sham, Sham?+?DMSO, HS/RES, or HS/RES?+?DMSO group, respectively (n?=?12 in each group). HS/RES was achieved by drawing blood to lower mean arterial pressure (40–45 mmHg for 60 min) followed by reinfusion with shed blood/saline mixtures. All rats received an intravenous injection of normal saline or DMSO immediately before resuscitation or at matching points relative to the sham groups. Arterial blood gas and histological assays (including histopathology, neutrophil infiltration, and lung water content) confirmed that HS/RES induced ALI. Significant increases in pulmonary expression of tumor necrosis factor-α (TNF-α), malondialdehyde, nuclear factor-kappa B (NF-κB), inducible nitric oxide synthase (iNOS), and cyclooxygenase 2 (COX-2) confirmed that HS/RES induced pulmonary inflammation and oxidative stress. DMSO significantly attenuated the pulmonary inflammation and ALI induced by HS/RES. The mechanisms for this may involve reducing inflammation and oxidative stress through inhibition of pulmonary NF-κB, TNF-α, iNOS, and COX-2 expression. |
| |
Keywords: | |
本文献已被 SpringerLink 等数据库收录! |
|